Robert Stockton Jones Jr.

Array ( [id] => 6639432 [patent_doc_number] => 20030212034 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-13 [patent_title] => 'Method of treatment of obesity and paralyzed muscle and ergogenic aids' [patent_app_type] => new [patent_app_number] => 10/297117 [patent_app_country] => US [patent_app_date] => 2002-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 12844 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20030212034.pdf [firstpage_image] =>[orig_patent_app_number] => 10297117 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7470154 [patent_doc_number] => 20040102519 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-27 [patent_title] => 'Use of arachidonic acid as a method of increasing skeletal muscle mass' [patent_app_type] => new [patent_app_number] => 10/306265 [patent_app_country] => US [patent_app_date] => 2002-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1987 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0102/20040102519.pdf [firstpage_image] =>[orig_patent_app_number] => 10306265 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 923118 [patent_doc_number] => 07319090 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-01-15 [patent_title] => 'Methods of treating cerebral ischemia' [patent_app_type] => utility [patent_app_number] => 10/306672 [patent_app_country] => US [patent_app_date] => 2002-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 18 [patent_no_of_words] => 9128 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/319/07319090.pdf [firstpage_image] =>[orig_patent_app_number] => 10306672 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6739822 [patent_doc_number] => 20030157191 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-21 [patent_title] => 'Methods and compositions for ameliorating the undesirable effects of chemotherapy' [patent_app_type] => new [patent_app_number] => 10/307245 [patent_app_country] => US [patent_app_date] => 2002-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6065 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0157/20030157191.pdf [firstpage_image] =>[orig_patent_app_number] => 10307245 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6697349 [patent_doc_number] => 20030109543 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-12 [patent_title] => 'Novel combination of an ADP-receptor blocking antiplatelet drug and a thromboxane A2 receptor antagonist and a method for inhibiting thrombus formation employing such combination' [patent_app_type] => new [patent_app_number] => 10/295347 [patent_app_country] => US [patent_app_date] => 2002-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11752 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0109/20030109543.pdf [firstpage_image] =>[orig_patent_app_number] => 10295347 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 490105 [patent_doc_number] => 07214709 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-05-08 [patent_title] => 'Arginine/ascorbic acid mixed powder as an oral supplement' [patent_app_type] => utility [patent_app_number] => 10/294862 [patent_app_country] => US [patent_app_date] => 2002-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2955 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/214/07214709.pdf [firstpage_image] =>[orig_patent_app_number] => 10294862 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6830462 [patent_doc_number] => 20030181520 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-25 [patent_title] => 'Methods of reversing and preventing cardiovascular pathologies' [patent_app_type] => new [patent_app_number] => 10/293399 [patent_app_country] => US [patent_app_date] => 2002-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12620 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20030181520.pdf [firstpage_image] =>[orig_patent_app_number] => 10293399 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6861752 [patent_doc_number] => 20030092760 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-15 [patent_title] => 'Therapeutic agent for renal failure' [patent_app_type] => new [patent_app_number] => 10/289626 [patent_app_country] => US [patent_app_date] => 2002-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5166 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20030092760.pdf [firstpage_image] =>[orig_patent_app_number] => 10289626 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7026832 [patent_doc_number] => 20050020609 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-27 [patent_title] => 'Pharmaceutical composition comprising a combination of metformin and a 4-oxobutanoic acid, and the use thereof for treating diabetes' [patent_app_type] => utility [patent_app_number] => 10/497145 [patent_app_country] => US [patent_app_date] => 2002-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2792 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20050020609.pdf [firstpage_image] =>[orig_patent_app_number] => 10497145 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6658221 [patent_doc_number] => 20030078262 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-24 [patent_title] => 'New drug combinations' [patent_app_type] => new [patent_app_number] => 10/288141 [patent_app_country] => US [patent_app_date] => 2002-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2807 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0078/20030078262.pdf [firstpage_image] =>[orig_patent_app_number] => 10288141 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6706851 [patent_doc_number] => 20030153585 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-14 [patent_title] => 'Pharmaceutical preparations containing 2-pyrrolidone as the dissolving intermediary' [patent_app_type] => new [patent_app_number] => 10/169396 [patent_app_country] => US [patent_app_date] => 2002-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5098 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20030153585.pdf [firstpage_image] =>[orig_patent_app_number] => 10169396 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6683925 [patent_doc_number] => 20030119789 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-26 [patent_title] => 'Compositions and methods for treating autoimmune disease' [patent_app_type] => new [patent_app_number] => 10/285011 [patent_app_country] => US [patent_app_date] => 2002-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 8106 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20030119789.pdf [firstpage_image] =>[orig_patent_app_number] => 10285011 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7403835 [patent_doc_number] => 20040023928 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-05 [patent_title] => 'Phosphonate nucleotide and thiadiazole compounds for the treatment of smallpox' [patent_app_type] => new [patent_app_number] => 10/273809 [patent_app_country] => US [patent_app_date] => 2002-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1183 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20040023928.pdf [firstpage_image] =>[orig_patent_app_number] => 10273809 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6650873 [patent_doc_number] => 20030104980 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-05 [patent_title] => 'Treating sexual desire disorders with flibanserin' [patent_app_type] => new [patent_app_number] => 10/272603 [patent_app_country] => US [patent_app_date] => 2002-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1570 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20030104980.pdf [firstpage_image] =>[orig_patent_app_number] => 10272603 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6829297 [patent_doc_number] => 20030180355 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-25 [patent_title] => 'Combination therapy for hypertension' [patent_app_type] => new [patent_app_number] => 10/274430 [patent_app_country] => US [patent_app_date] => 2002-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11928 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0180/20030180355.pdf [firstpage_image] =>[orig_patent_app_number] => 10274430 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 519349 [patent_doc_number] => 07189757 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-03-13 [patent_title] => 'Treatment of sleep disorders using CNS target modulators' [patent_app_type] => utility [patent_app_number] => 10/272510 [patent_app_country] => US [patent_app_date] => 2002-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 10 [patent_no_of_words] => 26951 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/189/07189757.pdf [firstpage_image] =>[orig_patent_app_number] => 10272510 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6814120 [patent_doc_number] => 20030073670 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-17 [patent_title] => 'Stabilized pharmaceutical compositions containing a calcium channel blocker' [patent_app_type] => new [patent_app_number] => 10/268308 [patent_app_country] => US [patent_app_date] => 2002-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6104 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0073/20030073670.pdf [firstpage_image] =>[orig_patent_app_number] => 10268308 [rel_patent_id] =>[rel_patent_doc_number] =>)